With a creatinine around 4 mg/dL, the main disadvantage of iodinated CT contrast is that the kidneys are likely already severely impaired, and contrast could be associated with further acute kidney injury. This may cause:

A creatinine value alone is not enough to decide. The key number is eGFR, whether kidney function is stable versus worsening, diabetes/heart failure/dehydration, and how essential the contrast scan is. With eGFR below 30 mL/min/1.73 m² or active AKI, contrast is generally a relative contraindication: clinicians weigh diagnostic benefit against renal risk, consider noncontrast imaging or ultrasound/MRI where appropriate, and may give IV hydration if safe. Current evidence suggests risk is low when eGFR is stable at or above 30. The ACR-NKF consensus summary supports this approach.

With a creatinine of 4 mg/dL, an elective iodinated contrast CT should usually be avoided or delayed until reviewed if any of the following apply:

It should not automatically be withheld when the scan is urgent or life-saving, such as suspected stroke, pulmonary embolism, aortic dissection, major trauma, bowel ischemia, or a serious infection requiring immediate source identification. In that setting, clinicians generally use the lowest necessary dose, assess volume status, consider IV isotonic fluids if safe, and involve radiology/nephrology as needed.

The decision should be based on eGFR and whether renal function is stable, not creatinine alone. A creatinine of 4 often corresponds to eGFR below 30, but age, sex, and body size matter. The ACR-NKF consensus identifies AKI and eGFR below 30 as the principal high-risk situations, while emphasizing that a necessary contrast-enhanced study should not be denied solely because of kidney-risk concern.